Aerogen announced today that it plans to invest about $308.5 million (€300 million) to expand operations in Ireland. The company — headquartered in Dangan, Galway — expects its investment to create 725 new jobs in Ireland over the next 10 years. According to Enterprise Ireland, the aerosol drug delivery company is Ireland’s largest indigenous medtech […]
Aerogen
Aerogen inks partnership to deliver COVID-19 vaccine with its mesh aerosol delivery tech
Aerogen and CanSinoBio announced today that they entered a partnership to deliver the latter’s COVID-19 vaccine with Aerogen’s technology. Galway, Ireland-based Aerogen’s proprietary vibrating mesh aerosol drug delivery technology will be used to deliver CanSinoBio’s recombinant novel coronavirus vaccine — Convidecia — under the development and commercial supply partnership. Commercial terms for the partnership were […]
Aerogen, Lyomark ink inhaled surfactant deal
Aerogen and Lyomark Pharma said today that they inked a deal to develop an inhaled surfactant treatment for respiratory distress syndrome in pre-term infants. The pact calls for the duo to combine a compound called AP-002, a nasally inhaled surfactant based on a combination of Lyomark’s Alveofact bovine lung surfactant and Aerogen’s PDAP nasal delivery technology. Aerogen […]
Aerogen touts study of Solo vibrating mesh for aerosol drug delivery
Aerogen today touted results from a study showing a 32% reduction in hospital admissions when patients were treated using its Solo vibrating mesh aerosol drug delivery system, compared to a small-volume nebulizer. The Chicago-based company’s vibrating mesh is used to treat respiratory disorders such as COPD, asthma, or influenza, all of which are exacerbated in the […]
